跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
吳 姿宜
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0003-1465-8762
電子郵件
sharah4910
tmu.edu
tw
h-index
2067
引文
28
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1985 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(55)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 Tzu-I Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Positron Emission Tomography
100%
Cervical Cancer
86%
Endometrial Cancer
78%
Prognostic Factor
71%
DNA Methylation
53%
Ovarian Cancer
51%
Cancer
50%
Extracorporeal Life Support
48%
Fluorodeoxyglucose F 18
48%
Cancer Diagnosis
48%
Extracorporeal Membrane Oxygenation
48%
Magnetic Resonance Imaging
40%
Wart Virus
40%
Recurrent Disease
40%
Malignant Neoplasm
38%
Neoplasm
32%
Hospital Mortality
31%
Overall Survival
30%
Adenocarcinoma
29%
Lymph Node Metastasis
28%
Carcinosarcoma
27%
Metastatic Carcinoma
27%
Acute Respiratory Distress Syndrome
26%
Cell Invasion
26%
Fluorine-18
25%
Artificial Respiration
24%
Hepatoma Cell
24%
Gynecological Oncology
24%
Papillomavirus Infection
24%
Ovarian Tumor
24%
Squamous Cell Carcinoma Antigen
24%
Thyroid Hormone Receptor
24%
Retrospective Cohort Study
24%
Disease
23%
Survival Rate
23%
Leiomyosarcoma
21%
Recurrence Free Survival
21%
Computer Assisted Tomography
21%
Pelvis
21%
CA-125
21%
Cell Migration
21%
Cancer Pathobiology
20%
Biological Marker
19%
Mesenchymal-Epithelial Transition
18%
Injury
18%
Progression Free Survival
18%
Tumor Invasion
18%
Cytotechnology
18%
Heart Arrest
17%
Retrospective Study
16%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
39%
Mesenchymal-Epithelial Transition
30%
Cell Migration
29%
Thyroid Hormone Receptor
24%
MicroRNA
24%
Thyroid Hormone
24%
Methylation
21%
Cell Invasion
21%
Promoter Region
16%
Cancer Cell
16%
Epigenetics
15%
Cancer Screening
15%
Wart Virus
13%
Cell Proliferation
13%
Carcinogenesis
12%
Glucose-Regulated Protein
12%
Transcription Initiation
12%
Protein Stability
12%
MMP3
12%
in Situ Hybridization
12%
Gelsolin
12%
Lipocalin-2
12%
Tumor Suppressor Gene
12%
Cell Motility
12%
Phosphatase
12%
Dioxygenase
12%
5-Hydroxymethylcytosine
12%
Catenin
12%
Epigenomics
12%
Serine Protease
12%
Phosphotransferase
12%
Kinase
12%
Tumor Progression
11%
Luciferase
9%
Chromatin Immunoprecipitation
9%
Cell Growth
9%
Histone
8%
Overall Survival
7%
Polymerase Chain Reaction
7%
LY294002
6%
Response Element
6%
Methylome
6%
Pyrosequencing
6%
Genetics
6%
Bisulfite
6%
Matrix Metalloproteinase
6%
Eicosanoid Receptor
6%
Ectopic Expression
5%
Microarrays
5%
Recurrence Free Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
36%
Thyroid Hormone Receptor
24%
Hospital Mortality
24%
Uterine Cervix Cancer
24%
Adult Respiratory Distress Syndrome
20%
Thyroid Hormone
19%
Recurrent Disease
18%
microRNA
18%
Tumor Invasion
16%
Neoplasm
16%
Malignant Neoplasm
15%
Cancer Growth
15%
Lymph Node Metastasis
13%
Overall Survival
12%
Metastasis
12%
Serine Proteinase
12%
Carcinosarcoma
12%
Adenosquamous Carcinoma
12%
Endometrium Cancer
12%
Lapatinib
12%
Neutrophil Gelatinase Associated Lipocalin
12%
Fluorodeoxyglucose F 18
12%
Ovary Tumor
12%
Ovary Cancer
12%
Cohort Study
12%
Protein Tyrosine Kinase Inhibitor
12%
Matrix Metalloproteinase
12%
Adenocarcinoma
12%
Squamous Cell Carcinoma Antigen
12%
Retrospective Study
11%
Disease
10%
Stromelysin
9%
Tumor Growth
7%
Survival Rate
6%
Recurrence Free Survival
6%
Chromatin Immunoprecipitation
6%
Chemoradiation Therapy
6%
Implant
6%
Chemotherapy
6%
Progression Free Survival
6%
Carcinogenesis
5%
Luciferase
5%
Cystitis
5%